Clinical Trial Update: Neoantigen-loaded DC Vaccine and Conventional Third-line Therapy for CRC Progressed After Second-line Treatment [NA]

View source ↗

Summary

This clinical trial evaluates a neoantigen-loaded dendritic cell vaccine plus conventional third-line therapy for colorectal cancer that progressed after second…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• Neoantigen-loaded DC Vaccine

Snippet

Sponsor: The First Affiliated Hospital of Nanchang University | Conditions: Colorectal Cancer (CRC) | NA | Status: RECRUITING